Regeneron Pharmaceuticals has signed a $2.32bn deal with Parabilis Medicines to develop therapeutic candidates, with a focus on AHCs.
The UK has received doses of antiviral medicine favipiravir as a precaution in case hantavirus spreads in the country. The medicine, developed by Fujifilm subsidiary Toyama Chemical in Japan, has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results